Complications During Transthoracic Lung Biopsies Under the Control of Computer Tomography (Diagnosis of Tumor-Like Formations)




lungs, transthoracic biopsy, computed tomography, lung cancer, pneumothorax, drugs, chronic, comorbid disorders


Currently, there is a recognized causal link between infectious diseases such as influenza, acute respiratory viral infections, and COVID-19, and the onset or worsening of various chronic and concurrent health conditions. These include, but are not limited to, cardiac disorders, both type I and II diabetes, bronchial asthma, chronic obstructive pulmonary disease, and injuries affecting the brain, chest, and lungs. Notably, complications arising from transthoracic lung biopsies, such as tumor-like formations and pneumothorax, have been observed. An in-depth analysis was conducted on complications following transthoracic biopsies, particularly those monitored via computer tomography. This involved a comprehensive review of existing scientific literature on the subject matter. It is imperative to underscore the critical need for appropriate pharmacotherapy to manage these complications, emphasizing the necessity of essential medications within the framework of legal interactions among doctors, patients, pharmacists, and lawyers. This research is inherently multidisciplinary, bridging the fields of medical science, pharmacology, and legal studies. The technique of conducting transthoracic biopsies with the guidance of computer tomography is meticulously detailed within this study. The discussion extends to the method's benefits, inherent risks, and unique characteristics, highlighting its utility in diagnosing and managing lung-related pathologies. Despite the potential for complications, this method is portrayed as largely safe, minimally invasive, and without significant adverse outcomes. It stands out as a promising avenue for future investigations, especially in the accurate diagnosis and management of lung diseases. This conclusion not only reflects the efficacy and safety of the transthoracic biopsy method when performed under computed tomography but also calls for ongoing research to further optimize and understand its application in clinical practice. The interplay between advanced diagnostic techniques, effective pharmacotherapy, and the legal framework governing healthcare practices forms a crucial nexus for enhancing patient care and outcomes in the face of complex respiratory diseases and associated conditions.

Author Biography

Olexandr Nevzghoda, Danylo Halytsky Lviv National Medical University

PhD in Medical Sciences, Associate Professor, Danylo Halytsky Lviv National Medical University, Ukraine


Episode 59 - Flu & COVID-19. WHO. 22.10.2021. URL:

Acute respiratory infections in the EU/EEA: epidemiological update and current public health recommendations. ECDC.Europa. 15.12.2023. URL:

Raghu G., Meyer K.C. Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease. European. Respiratory Review. 2021. Vol.30. Р.1-11. 210094. DOI: DOI:

Kenney A.D., Aron S.L., Gilbert C. еt al. Influenza virus replication in cardiomyocytes drives heart dysfunction and fibrosis. Science. 11.05.2022. Vol. 8. No.19. URL: DOI:

Nevzghoda O., Nevzghoda, A. Thoracoscopy and Video-Assisted Thoracoscopy in Diagnostics of Pneumothoraxes, Traumatic Defeats of Thorax with Pneumothoraxes. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No 4. P. 1-10. URL: DOI:

Nevzghoda O. Interdisciplinary study of health disorders associated with comorbid addictions. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No. 3. P. 1-13. DOI: DOI:

Nevzhoda A., Nevzhoda O. Immunological criteria of autoaggressionof bronchial asthma: markers for prediction of the course and selection of adequate pharmacotherapy. SSP Modern Pharmacy and Medicine.2023. Vol. 3. No 1. P. 1-7. DOI: DOI:

Shapovalova V. Post-Traumatic Stress Disorder: Administration, Clinical and Pharmacological, Organizational and Legal, Pharmaceutical Management, Recent Case Studies. SSP Modern Pharmacy and Medicine. 2024. Vol. 4. No 1. Р. 1-8. DOI: DOI:

Shapovalova V. Pharmacotherapy of Depressive Disorders in Conditions of Coronavirus Disease: Pharmacoeconomic Experimental Study. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No 3. P. 1-11. DOI: DOI:

Shapovalova V. Interdisciplinary pharmacoeconomic research concerning the pharmacotherapy of Аlcoholic Hepatitis in conditions of COVID-19 pandemic. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No. 2. P. 1-10. DOI: DOI:

Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1-24. DOI: DOI:

Shapovalov V. Multidisciplinary study of medical errors in the system of legal relations between "Doctor-Patient-Pharmacist-Advocate" during the circulation of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No. 2. P. 1-11. DOI: DOI:

Shapovalova V. Monkeypox Virus – New Challenges of Modernity: Experimental Organizational and Legal, Clinical and Pharmacological Studies. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No 3. Р. 1-15. DOI: DOI:

Shapovalova V. The ICD-11 For the Twenty-First Century: The First View from The Organizational, Legal, Clinical and Pharmacological Aspects. SSP Modern Pharmacy and Medicine 2022. Vol. 2. No 1. P. 1-13. DOI: DOI:

SARS, influenza and COVID-19: since October, 1.9 million people have fallen ill in Ukraine, 56% of them are children. Ministry of Health of Ukraine. 04.01.2024. URL:

The Law of Ukraine "On the Protection of the Population from Infectious Diseases". Information of the Verkhovna Rada of Ukraine. 2000. No. 29. Art. 228. Edition of 01.01.2024. URL:

Order of the Ministry of Health of Ukraine dated September 27, 2023 No. 1600 "On the implementation of subsection 1.1 of paragraph 1 of the Decision of the operational headquarters of the Ministry of Health of Ukraine on responding to situations of the spread of infectious diseases that can be prevented by vaccination dated September 15, 2023." Ministry of Health of Ukraine. 09/27/2023. URL:

Order of the Ministry of Health of Ukraine dated 07.06.2019 No. 1319 "On the creation of an operational headquarters of the Ministry of Health of Ukraine to respond to situations of the spread of infectious diseases that can be prevented by vaccination." Verkhovna Rada of Ukraine. Editorial from 03.05.2023. URL:

Shveda O. Epidemic situation in Lviv Oblast. How to distinguish flu from ARVI and how many people got sick. Suspilne. 13.01.2024. URL:

Flu and SARS are raging in Kyiv: children are getting sick en masse. SQ. 30.01.2024. URL:

Flu and COVID-19 are raging in Kyiv: 10 people died in a week. SQ. 09.01.2024. URL:

Shapovalova V. An Innovative multidisciplinary study of the availability of coronavirus vaccines in the world. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.2. P.1–17 URL: DOI:

Gryzodub O., Shapovalov V. Quality Systems in Pharmacy: Multidisciplinary Context of the State Pharmacopoeia of Ukraine. SSP Modern Law and Practice. 2023. Vol. 3. No 1. Р. 1-23. DOI: DOI:

Shapovalov V., Butko L., Shapovalov V. Organizational and legal study of quarantine restrictions in the spread of coronavirus disease in Ukraine. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. Nо 2. P. 1-12. DOI: DOI:

Human medicines: highlights of 2023. EMA. 16.01.2024. URL:

Almost 13,000 decisions in the field of drug registration in Ukraine - 2023 data as of December 22. State expert center of the Ministry of Health of Ukraine. 26.12.2023.URL:

Nevzhoda O.A. Differentiation of tumular formations of lungs by means of transthoracic biopsy under control of computer tomography. Clinical Pharmacy, Pharmacotherapy, Medical Standardization. 2015. No 3-4 (28-29). Р. 55-59. URL:

WHO Classification of Tumours Editorial Board. Thoracic Tumours. 5th ed. International Agency for Research on Cancer, Lyon, France: WHO IARC. 2021. URL:

Nicholson A.G., Tsao M.S., Beasley M.B. et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. Journal of Thoracic Oncology. 2021. Vol. 17. Issue 3. P. 362-387. URL: DOI:

Tsao M.S., Nicholson A.G., Maleszewski J.J. et al. Introduction to 2021 WHO Classification of Thoracic Tumors. Journal of Thoracic Oncology 2022. Vol. 3. Issue 1. e1-e4. URL: DOI:

Sinner W.N. Transthoracic needle biopsy of small peripheral malignant lung lesions. Invest. Radiol. 1973. Vol. 8. No. 5. Р. 305-319. URL: DOI:

Berquist T.H., Bailey P.B., Cortese D.A. et al. Transthoracic needle biopsy: accuracy and complications in relation to location and type of lesion. Mayo. Clin. Proc. 1980. Vol. 55. No. 8. Р. 475-81. URL:

Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients. Pharmacia. 2018. Vol.65. Nо.2. P.17-22. URL:

Shapovalov V. Multidisciplinary study of the level of availability of medicines for cancer patients based on the principles of pharmaceutical law, evidence-based pharmacy, clinical pharmacy, forensic pharmacy, and the organization of a pharmaceutical case. Actual Problems of Medicine and Pharmacy. 2023. Vol.4. No.1. P.1–20. URL: DOI:

Sinner W.N., Zajicek J. Implantation Metastasis after Percutaneous Transthoracic Needle Aspiration Biopsy. Sage Journals. 1976. Vol. 17. Iss.4. Р.473-480. URL: DOI:

Choi M., Kim Y., Hong Y. et al. Transthoracic needle biopsy using a C-arm cone-beam CT system: diagnostic accuracy and safety. Br. J. Radiol. 2012. Vol.85 (1014). e182–e187. URL: DOI:

Heerink W.J., Bock G.H., Jonge G.J. et al. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur. Radiol. 2017. Vol. 27. No 1. Р. 138-148. DOI:

Vachani А., Zhou М., Ghosh S. et al. Complications After Transthoracic Needle Biopsy of Pulmonary Nodules: A Population-Level Retrospective Cohort Analysis. Journal of the American College of Radiology. 2022. Vol. 19. Iss. 10. P. 1121-1129. URL: DOI:

Bae K., Ha J.Y., Jeon K.N. Pneumothorax after CT-guided transthoracic lung biopsy: a comparison between immediate and delayed occurrenK. PLoS ONE. 2020. Vol.15. No.8. e0238107. URL: DOI:

Lang D., Reinelt V., Horner A. Complications of CT-guided transthoracic lung biops: A short report on current literature and a case of systemic air embolism. Wien. Klin. Wochenschr. 2018. Vol.130. No.7-8. Р.288-292. URL: DOI:

Lung cancer. Cancer Council. 2024. URL:

Babak O.Ya., Tverezovska I.I., Zheleznyakova N.M. etc. Management of a patient with hemoptysis. Modern practice of internal medicine with emergency conditions: method. order for students and intern doctors. Kharkiv: KhNMU. 2021. 28 p.

Hemoptysis. Doctor Thinking. 2024. URL:

Shmakova I.P. Management of a patient with hemoptysis, with a chronic cough. Management of a patient with respiratory failure. Odesa: Odesa National Medical University - Department of Rehabilitation Medicine. 2021. 23 p.

Serap Y., Asli Tanrivermis S., Leman T. et al. Frequency of complications and risk factors associated with computed tomography guided core needle lung biopsies. ANN SAUDI MED. 2021. Vol.41. No.2. P.78-85 URL: DOI:

Zarogoulidis P., Kioumis I., Pitsiou G. et al. Pneumothorax: from definition to diagnosis and treatment. J. Thorac. Dis. 2014 No.4. Р.372-376. URL:

Weiser T.G. Pneumothorax (tension). MSD Manuals. 2022. URL:

Fomichova N.I., Kazimirko N.K., Pustovyi Y.G. et al. Critical conditions in respiratory tuberculosis. Zaporizhzhia: Zaporizhia State Medical University. 2016. 160 p.

Martti Teikari. Instruction 00133. Pneumothorax. 2017. URL:




How to Cite

Nevzghoda, O. (2024). Complications During Transthoracic Lung Biopsies Under the Control of Computer Tomography (Diagnosis of Tumor-Like Formations). SSP Modern Pharmacy and Medicine, 4(1), 1–10.



Health Sciences. Medicine